Bill
HR 4780
The USTRx Act aims to lower prescription drug costs by ensuring price transparency, allowing drug importation, and enabling government price negotiations for Medicare.
The USTRx Act (HR 4780) aims to enhance the accessibility and affordability of prescription medications in the United States. The bill seeks to address the rising costs of pharmaceuticals and improve the overall efficiency of the prescription drug supply chain. By implementing various reforms, the USTRx Act intends to ensure that patients can obtain necessary medications without facing prohibitive financial barriers.
While the specific text of the bill is not provided, the USTRx Act is expected to include several key provisions, which may encompass:
Price Transparency: Mandating that pharmaceutical companies disclose pricing information to consumers and healthcare providers to promote informed decision-making.
Importation of Drugs: Allowing the importation of safe and effective prescription drugs from other countries to increase competition and lower prices.
Negotiation of Drug Prices: Empowering the federal government to negotiate prices for certain high-cost medications, particularly those covered under Medicare.
Support for Generic Drugs: Encouraging the development and approval of generic medications to provide more affordable alternatives to brand-name drugs.
The USTRx Act would primarily impact:
Patients: Individuals requiring prescription medications would benefit from potentially lower prices and increased access to necessary treatments.
Pharmaceutical Companies: Drug manufacturers may face new regulations regarding pricing transparency and negotiations, which could affect their profit margins.
Healthcare Providers: Doctors and pharmacists would have access to clearer pricing information, enabling them to better assist patients in making cost-effective choices.
Introduced: The bill was introduced in the House of Representatives on July 29, 2025.
Committee Referral: Following its introduction, HR 4780 was referred to the House Committee on Ways and Means for further consideration.
The USTRx Act is sponsored by:
These sponsors represent a coalition of lawmakers advocating for reforms in the pharmaceutical sector, reflecting a bipartisan interest in addressing drug pricing issues.
The USTRx Act represents a significant legislative effort to reform the prescription drug market in the United States. By focusing on price transparency, importation, and negotiation, the bill aims to make medications more affordable and accessible for all Americans. As the bill progresses through the legislative process, further details and specific provisions will be clarified, providing a clearer picture of its potential impact.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
